Reginald Kerolle’s Post

Today we will start off with a workshop on social identity and positionality in Public Health research and practice. It is important to move away from the reductionistic, vertical and positivistic views that govern knowledge and action in Public Health. Students and future practitioners should take a step back and be reflective on their social identity and position. Building on the published work from Jacobson & Mustafa students will map their own social identity and reflect on how these issues make them feel and how they make work with various communities harder or easier. Europubhealth EHESP - École des hautes études en santé publique

The key domains that make up the political determinants of health. 🔑 ⚖️ "The medical and public health communities widely recognize that the social determinants of health (SDoH) deserve the attention of policymakers, public health professionals, medical schools, and researchers". #HealthEquity #SocialJustice #PublicHealth Reference: The Social Determinants of Health? Time to Focus on the Political Determinants of Health! Ranit Mishori, MD, MHS, FAAFP

Thrilled to finish the first course in the field of evaluation large scale public health programs from one of the most prestigious public health schools in the world. This course provided me with the real knowledge to understand the evaluation journey starting from stakeholders involvement to impact model designing and how to construct evaluation plan for large scale programs in real world settings. I deeply recommend it as a powerful start. #public_health #evaluating_health_programs

"How can we better and more accurately detect and predict suicide risk?" The new study, titled "RNA Editing Patterns as Blood Biomarkers for Predicting Suicide Risk," led by a diverse team of Kent State researchers, including the Kent State Center for Public Policy and Health, will test if a blood test can assess suicide risk. Read more and follow the Kent State Center for Public Policy and Health for more updates!

The UW INSIGHT High School Program is building the next generation of doctors, researchers, & public health experts. The 4 week #VirtualProgram is designed to introduce students to public health, research, & medicine over the summer. Interested? Learn more: bit.ly/hsINSIGHT

This past weekend, I had the privilege and honor to share our personal narrative--experiences and insights on public health leadership for learners of health policy and administration at the College of Public Health, UP Manila. Thanks again for the invitation. We asked hard questions and ventured to give our well-thought-out answers to help future public health leaders tread their chosen paths in public health and carve out their own niche. Teasing out what's needed in terms of public health leadership in the post-COVID world, we shared the following 3Cs acronym and what each stands for: 1. Competent leadership More is expected because health crises in multiple forms threaten the health and well-being of people. 2. Collaborative approach Most of the solutions to our health issues lies outside the realm of health; social, economic, political determinants of health are more pervasive. 3. Compassionate care Those who are the last, least and lost need to be taken care of because of growing health inequity. This is so critical that we believe this topic deserves discussion not only in colleges of public health across the country but also in the realm of public health policy and practice.

Arizona Care Network Population Health Pharmacist Tannaz Farahani, PharmD, MPH, sits down with hematology and blood disorder specialist Dr. Amit Mehta, a practicing physician in North Carolina and a clinical adjunct faculty member at Duke University. Check out the video below to get his insights on the following topics: 🔴 Leading causes of blood clots 🔍 Critical warning signs to look out for 👨⚕️ Treatment options available for different clots (DVT, PE, VTE)

In early 2023, I predicted a rapid increase in heart failure based on scientific extrapolation. Currently, we are beginning to see this reality unfold across the United States. While it might be easier to stay silent about the seriousness of this situation, especially given the risk of censorship, remaining silent would not align with the principles of good medicine. As healthcare professionals and scientists, it’s our duty to ask difficult questions and address emerging patterns, even when they challenge the status quo. Only by confronting these issues can we hope to find solutions and protect public health. Your thoughts and engagement on this matter are invaluable. Together, we can work toward greater awareness and action. #covid #medicine #research

Key takeaways from yesterday's Association of Schools and Programs of Public Health (ASPPH) webinar: "What the US Presidential Election Outcome Means for Public Health." Speaker Ali S. Khan, MD, MPH, Dean, University of Nebraska Medicine Medical Center College of Public Health: 1) "Public health can be political... We cannot be perceived as partisan." 2) "There are 39 credited public health schools and 77 credited programs in red states. It is possible to do really good public health...if you're in a red state." 3) U.S. Department of Health and Human Services (HHS) priorities in 2025 may include: child health, substance abuse, mental health, obesity, rural health, preparedness (#H5 Bird Flu). "We'll see, time will tell." 4) "Public health has long been viewed as an invisible safety net - we cannot be invisible anymore." 5) "We're all scientists. We should have a sense of curiousity." Speaker: Mark Mioduski, Principal and Director, Cornerstone Government Affairs: (1) U.S. Department of Health and Human Services (HHS) funding in 2025 is "a wild card." Funding for inequalities and disparities will "fall out of favor in next year's appropriations." "New threats we've never seen before." You can view the webinar recording: https://lnkd.in/eSu9rRG6

Inconvenient analysis of science more than anything else here… Predicted… wow. First, to mention COVID vaccines do not prevent infections is pure heresy. And how grandiose is such a cardiovascular epidemic risk claim ? And to link this to COVID while the epidemic started more than 10 years before COVID even existed (ref1)? Have you forgotten that obesity and sedentarism are key drivers of CV risks. The data on cardiomyopathy that you’re trying to link to COVID vaccines clearly shows that the incidence in unvaccinated individuals is 7-10 fold greater than in vaccinated individuals but that outcomes clearly are favorable in the vaccinated population (ref2). And the literature has clearly showed that vaccination is cardioprotective, completely proving you wrong (ref3).The magnitude of the lower risk—which ranged from a 45% to 81% relative risk reduction—was greatest during the first month after infection, although vaccinated participants had a reduced chance of these cardiovascular events through 1 year. Even the AZ vaccine(ref4), a paria in the mind of some, had positive CV effects;Adjusted hazard ratios (aHRs) for arterial thrombotic events 13 to 24 weeks after first vaccine dose were 0.99 (95% confidence interval [CI], 0.97 to 1.02) after AstraZeneca, and 0.90 (0.88 to 0.93) after Pfizer vaccines. Corresponding aHRs after second doses were 0.73 (0.70 to 0.76) and 0.80 (0.77 to 0.83), respectively, the authors said.  "For all vaccine brands and doses, aHRs in the first few weeks were lower than in later weeks,". So basically (ref5), vaccination reduces significantly risk of cardiovascular events by important levels: decreased risks of cardiovascular events post-vaccination were observed, especially after dose three (HRs for dose three ranging from .69 to .81), while replicating the increased risk of myocarditis and pericarditis 1–2 weeks after COVID-19 mRNA vaccination. Slightly increased risks, similar across vaccines, were observed for extrasystoles [HR 1.17 (95% CI 1.06–1.28) for dose one and HR 1.22 (95% CI 1.10–1.36) for dose two, stronger in elderly and males] but not for arrhythmias and for transient ischaemic attack [HR 1.13 (95% CI 1.05–1.23), mainly in elderly] but not for stroke. https://lnkd.in/gABGrJ3v https://lnkd.in/gbui3VKa https://lnkd.in/gavQ_5i8 https://lnkd.in/eX5WFsDn https://lnkd.in/gSQmphwu